Researchers develop new method for identifying lung nodules

July 16, 2012

Pulmonary nodules are common, but few studies of lung nodule identification and clinical evaluation have been performed in community settings. Researchers from Kaiser Permanente Southern California identified 7,112 patients who had one or more nodules by using existing information within the electronic medical record.

Their study presented in the August 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) , showed how researchers developed and implemented a new method for identifying in community-based settings.

The researchers used a combination of ICD-9 codes, CPT codes and an algorithm for (NLP) to classify the nodules. This automated method had a 96 percent sensitivity and 86 percent specificity compared to clinician review.

The authors suggest that the automated process, "could be used to study the incidence and prevalence of lung nodules in large popula¬tions, with the caveat that approximately 13 percent of cases identi¬fied by the automated method would not meet our definition of one or more nodules (e.g., be false-positives)."

Since this study favored sensitivity over specificity, the authors advise that the method "could be used as a sensitive first step to be followed by more specific review of radiology transcripts or actual imaging studies."

As screening programs for lung cancer have proven to be beneficial in specific high-risk populations, this study also provides useful information for the study of screen-detected nodules.

Explore further: Lung nodule matching software dramatically increases radiologists' efficiency

Related Stories

Lung nodule matching software dramatically increases radiologists' efficiency

June 26, 2012
An automated lung nodule matching program can improve radiologists' efficiency almost two-fold, a first of its kind study shows.

A marker in the lining of the lungs could be useful diagnostic technique for lung cancer screening

May 15, 2012
The most recent research released in June's Journal of Thoracic Oncology says molecular biomarkers in the tissue and fluid lining the lungs might be an additional predictive technique for lung cancer screening.

Lower dosage CT-guided lung biopsy protocol maintains quality, minimizes exposure

March 25, 2012
New guidelines for CT-guided biopsies of lung nodules significantly reduce radiation exposure allowing individuals the benefit of the procedure, which may cut down on overall lung cancer deaths. This research is being presented ...

Despite obstacles, fine needle aspiration might be best diagnostic tool

April 15, 2012
Screening for lung cancer with low dose CT scans has been shown to save lives. However, research shows that when CT scans reveal nodules in the lungs, it is not cancerous 96 percent of the time. As a result, scientists are ...

Recommended for you

New findings explain how UV rays trigger skin cancer

October 18, 2017
Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from ...

Drug yields high response rates for lung cancer patients with harsh mutation

October 18, 2017
A targeted therapy resurrected by the Moon Shots Program at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries ...

Possible new immune therapy target in lung cancer

October 18, 2017
A study from Bern University Hospital in collaboration with the University of Bern shows that so-called perivascular-like cells from lung tumors behave abnormally. They not only inadequately support vascular structures, but ...

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

New bowel cancer drug target discovered

October 17, 2017
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.